aluates Reports

$ 0.0

Automative

Global Rare Biomarkers Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-22A16952

BUY CHAPTERS

Global Rare Biomarkers Market Research Report 2024

Code: QYRE-Auto-22A16952

Report

May 2024

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Roche

Thermo Fisher Scientific

Abbott

Qiagen NV

PerkinElmer Inc

Merck KGaA

Bio Rad Laboratories

Enzo Biochem

Charles River Laboratories International

Eurofins Scientific

Agilent Technologies

Bruker

Siemens Healthineers

Epigenomics

GE Healthcare

Diaceutics

Rare Biomarkers Market

The global Rare Biomarkers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Rare Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Rare Biomarkers in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Rare Biomarkers include Roche, Thermo Fisher Scientific, Abbott, Qiagen, PerkinElmer, Merck KGaA, Bio-Rad Laboratories, Enzo Biochem, Charles River Laboratories International, Eurofins Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Rare Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Biomarkers.

The Rare Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rare Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rare Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rare Biomarkers Market Report

Report Metric	Details
Report Name	Rare Biomarkers Market
Segment by Type	Circulating Cell Free DNA (ccfDNA) Circulating Tumor Cells (CTCs) Exosomes/Extracellular Vesicles Circulating Cell Free RNA (ccfRNA) / miRNA
Segment by Application	Diagnostics Drug Development Disease Discovery Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Thermo Fisher Scientific, Abbott, Qiagen, PerkinElmer, Merck KGaA, Bio-Rad Laboratories, Enzo Biochem, Charles River Laboratories International, Eurofins Scientific, Agilent Technologies, Bruker, Siemens Healthineers, Epigenomics, GE HealthCare, Diaceutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rare Biomarkers Market report?

Ans: The main players in the Rare Biomarkers Market are Roche, Thermo Fisher Scientific, Abbott, Qiagen, PerkinElmer, Merck KGaA, Bio-Rad Laboratories, Enzo Biochem, Charles River Laboratories International, Eurofins Scientific, Agilent Technologies, Bruker, Siemens Healthineers, Epigenomics, GE HealthCare, Diaceutics

What are the Application segmentation covered in the Rare Biomarkers Market report?

Ans: The Applications covered in the Rare Biomarkers Market report are Diagnostics, Drug Development, Disease Discovery, Other

What are the Type segmentation covered in the Rare Biomarkers Market report?

Ans: The Types covered in the Rare Biomarkers Market report are Circulating Cell Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles, Circulating Cell Free RNA (ccfRNA) / miRNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rare Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Circulating Cell Free DNA (ccfDNA)

1.2.3 Circulating Tumor Cells (CTCs)

1.2.4 Exosomes/Extracellular Vesicles

1.2.5 Circulating Cell Free RNA (ccfRNA) / miRNA

1.3 Market by Application

1.3.1 Global Rare Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diagnostics

1.3.3 Drug Development

1.3.4 Disease Discovery

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rare Biomarkers Market Perspective (2019-2030)

2.2 Global Rare Biomarkers Growth Trends by Region

2.2.1 Global Rare Biomarkers Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Rare Biomarkers Historic Market Size by Region (2019-2024)

2.2.3 Rare Biomarkers Forecasted Market Size by Region (2025-2030)

2.3 Rare Biomarkers Market Dynamics

2.3.1 Rare Biomarkers Industry Trends

2.3.2 Rare Biomarkers Market Drivers

2.3.3 Rare Biomarkers Market Challenges

2.3.4 Rare Biomarkers Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rare Biomarkers Players by Revenue

3.1.1 Global Top Rare Biomarkers Players by Revenue (2019-2024)

3.1.2 Global Rare Biomarkers Revenue Market Share by Players (2019-2024)

3.2 Global Rare Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Rare Biomarkers Revenue

3.4 Global Rare Biomarkers Market Concentration Ratio

3.4.1 Global Rare Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rare Biomarkers Revenue in 2023

3.5 Global Key Players of Rare Biomarkers Head office and Area Served

3.6 Global Key Players of Rare Biomarkers, Product and Application

3.7 Global Key Players of Rare Biomarkers, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Biomarkers Breakdown Data by Type

4.1 Global Rare Biomarkers Historic Market Size by Type (2019-2024)

4.2 Global Rare Biomarkers Forecasted Market Size by Type (2025-2030)

5 Rare Biomarkers Breakdown Data by Application

5.1 Global Rare Biomarkers Historic Market Size by Application (2019-2024)

5.2 Global Rare Biomarkers Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Rare Biomarkers Market Size (2019-2030)

6.2 North America Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Rare Biomarkers Market Size by Country (2019-2024)

6.4 North America Rare Biomarkers Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rare Biomarkers Market Size (2019-2030)

7.2 Europe Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Rare Biomarkers Market Size by Country (2019-2024)

7.4 Europe Rare Biomarkers Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rare Biomarkers Market Size (2019-2030)

8.2 Asia-Pacific Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Rare Biomarkers Market Size by Region (2019-2024)

8.4 Asia-Pacific Rare Biomarkers Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rare Biomarkers Market Size (2019-2030)

9.2 Latin America Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Rare Biomarkers Market Size by Country (2019-2024)

9.4 Latin America Rare Biomarkers Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rare Biomarkers Market Size (2019-2030)

10.2 Middle East & Africa Rare Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Rare Biomarkers Market Size by Country (2019-2024)

10.4 Middle East & Africa Rare Biomarkers Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Rare Biomarkers Introduction

11.1.4 Roche Revenue in Rare Biomarkers Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Rare Biomarkers Introduction

11.2.4 Thermo Fisher Scientific Revenue in Rare Biomarkers Business (2019-2024)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Rare Biomarkers Introduction

11.3.4 Abbott Revenue in Rare Biomarkers Business (2019-2024)

11.3.5 Abbott Recent Development

11.4 Qiagen

11.4.1 Qiagen Company Details

11.4.2 Qiagen Business Overview

11.4.3 Qiagen Rare Biomarkers Introduction

11.4.4 Qiagen Revenue in Rare Biomarkers Business (2019-2024)

11.4.5 Qiagen Recent Development

11.5 PerkinElmer

11.5.1 PerkinElmer Company Details

11.5.2 PerkinElmer Business Overview

11.5.3 PerkinElmer Rare Biomarkers Introduction

11.5.4 PerkinElmer Revenue in Rare Biomarkers Business (2019-2024)

11.5.5 PerkinElmer Recent Development

11.6 Merck KGaA

11.6.1 Merck KGaA Company Details

11.6.2 Merck KGaA Business Overview

11.6.3 Merck KGaA Rare Biomarkers Introduction

11.6.4 Merck KGaA Revenue in Rare Biomarkers Business (2019-2024)

11.6.5 Merck KGaA Recent Development

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Details

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Rare Biomarkers Introduction

11.7.4 Bio-Rad Laboratories Revenue in Rare Biomarkers Business (2019-2024)

11.7.5 Bio-Rad Laboratories Recent Development

11.8 Enzo Biochem

11.8.1 Enzo Biochem Company Details

11.8.2 Enzo Biochem Business Overview

11.8.3 Enzo Biochem Rare Biomarkers Introduction

11.8.4 Enzo Biochem Revenue in Rare Biomarkers Business (2019-2024)

11.8.5 Enzo Biochem Recent Development

11.9 Charles River Laboratories International

11.9.1 Charles River Laboratories International Company Details

11.9.2 Charles River Laboratories International Business Overview

11.9.3 Charles River Laboratories International Rare Biomarkers Introduction

11.9.4 Charles River Laboratories International Revenue in Rare Biomarkers Business (2019-2024)

11.9.5 Charles River Laboratories International Recent Development

11.10 Eurofins Scientific

11.10.1 Eurofins Scientific Company Details

11.10.2 Eurofins Scientific Business Overview

11.10.3 Eurofins Scientific Rare Biomarkers Introduction

11.10.4 Eurofins Scientific Revenue in Rare Biomarkers Business (2019-2024)

11.10.5 Eurofins Scientific Recent Development

11.11 Agilent Technologies

11.11.1 Agilent Technologies Company Details

11.11.2 Agilent Technologies Business Overview

11.11.3 Agilent Technologies Rare Biomarkers Introduction

11.11.4 Agilent Technologies Revenue in Rare Biomarkers Business (2019-2024)

11.11.5 Agilent Technologies Recent Development

11.12 Bruker

11.12.1 Bruker Company Details

11.12.2 Bruker Business Overview

11.12.3 Bruker Rare Biomarkers Introduction

11.12.4 Bruker Revenue in Rare Biomarkers Business (2019-2024)

11.12.5 Bruker Recent Development

11.13 Siemens Healthineers

11.13.1 Siemens Healthineers Company Details

11.13.2 Siemens Healthineers Business Overview

11.13.3 Siemens Healthineers Rare Biomarkers Introduction

11.13.4 Siemens Healthineers Revenue in Rare Biomarkers Business (2019-2024)

11.13.5 Siemens Healthineers Recent Development

11.14 Epigenomics

11.14.1 Epigenomics Company Details

11.14.2 Epigenomics Business Overview

11.14.3 Epigenomics Rare Biomarkers Introduction

11.14.4 Epigenomics Revenue in Rare Biomarkers Business (2019-2024)

11.14.5 Epigenomics Recent Development

11.15 GE HealthCare

11.15.1 GE HealthCare Company Details

11.15.2 GE HealthCare Business Overview

11.15.3 GE HealthCare Rare Biomarkers Introduction

11.15.4 GE HealthCare Revenue in Rare Biomarkers Business (2019-2024)

11.15.5 GE HealthCare Recent Development

11.16 Diaceutics

11.16.1 Diaceutics Company Details

11.16.2 Diaceutics Business Overview

11.16.3 Diaceutics Rare Biomarkers Introduction

11.16.4 Diaceutics Revenue in Rare Biomarkers Business (2019-2024)

11.16.5 Diaceutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

Roche

Thermo Fisher Scientific

Abbott

Qiagen NV

PerkinElmer Inc

Merck KGaA

Bio Rad Laboratories

Enzo Biochem

Charles River Laboratories International

Eurofins Scientific

Agilent Technologies

Bruker

Siemens Healthineers

Epigenomics

GE Healthcare

Diaceutics

List of Tables

Table 1. Global Rare Biomarkers Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Circulating Cell Free DNA (ccfDNA)

Table 3. Key Players of Circulating Tumor Cells (CTCs)

Table 4. Key Players of Exosomes/Extracellular Vesicles

Table 5. Key Players of Circulating Cell Free RNA (ccfRNA) / miRNA

Table 6. Global Rare Biomarkers Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Rare Biomarkers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Rare Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Rare Biomarkers Market Share by Region (2019-2024)

Table 10. Global Rare Biomarkers Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Rare Biomarkers Market Share by Region (2025-2030)

Table 12. Rare Biomarkers Market Trends

Table 13. Rare Biomarkers Market Drivers

Table 14. Rare Biomarkers Market Challenges

Table 15. Rare Biomarkers Market Restraints

Table 16. Global Rare Biomarkers Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Rare Biomarkers Market Share by Players (2019-2024)

Table 18. Global Top Rare Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Biomarkers as of 2023)

Table 19. Ranking of Global Top Rare Biomarkers Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Rare Biomarkers Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Rare Biomarkers, Headquarters and Area Served

Table 22. Global Key Players of Rare Biomarkers, Product and Application

Table 23. Global Key Players of Rare Biomarkers, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Rare Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Rare Biomarkers Revenue Market Share by Type (2019-2024)

Table 27. Global Rare Biomarkers Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Rare Biomarkers Revenue Market Share by Type (2025-2030)

Table 29. Global Rare Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Rare Biomarkers Revenue Market Share by Application (2019-2024)

Table 31. Global Rare Biomarkers Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Rare Biomarkers Revenue Market Share by Application (2025-2030)

Table 33. North America Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Rare Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Rare Biomarkers Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Rare Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Rare Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Rare Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Rare Biomarkers Product

Table 51. Roche Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Thermo Fisher Scientific Company Details

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Rare Biomarkers Product

Table 56. Thermo Fisher Scientific Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 57. Thermo Fisher Scientific Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Rare Biomarkers Product

Table 61. Abbott Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. Qiagen Company Details

Table 64. Qiagen Business Overview

Table 65. Qiagen Rare Biomarkers Product

Table 66. Qiagen Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 67. Qiagen Recent Development

Table 68. PerkinElmer Company Details

Table 69. PerkinElmer Business Overview

Table 70. PerkinElmer Rare Biomarkers Product

Table 71. PerkinElmer Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 72. PerkinElmer Recent Development

Table 73. Merck KGaA Company Details

Table 74. Merck KGaA Business Overview

Table 75. Merck KGaA Rare Biomarkers Product

Table 76. Merck KGaA Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 77. Merck KGaA Recent Development

Table 78. Bio-Rad Laboratories Company Details

Table 79. Bio-Rad Laboratories Business Overview

Table 80. Bio-Rad Laboratories Rare Biomarkers Product

Table 81. Bio-Rad Laboratories Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 82. Bio-Rad Laboratories Recent Development

Table 83. Enzo Biochem Company Details

Table 84. Enzo Biochem Business Overview

Table 85. Enzo Biochem Rare Biomarkers Product

Table 86. Enzo Biochem Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 87. Enzo Biochem Recent Development

Table 88. Charles River Laboratories International Company Details

Table 89. Charles River Laboratories International Business Overview

Table 90. Charles River Laboratories International Rare Biomarkers Product

Table 91. Charles River Laboratories International Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 92. Charles River Laboratories International Recent Development

Table 93. Eurofins Scientific Company Details

Table 94. Eurofins Scientific Business Overview

Table 95. Eurofins Scientific Rare Biomarkers Product

Table 96. Eurofins Scientific Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 97. Eurofins Scientific Recent Development

Table 98. Agilent Technologies Company Details

Table 99. Agilent Technologies Business Overview

Table 100. Agilent Technologies Rare Biomarkers Product

Table 101. Agilent Technologies Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 102. Agilent Technologies Recent Development

Table 103. Bruker Company Details

Table 104. Bruker Business Overview

Table 105. Bruker Rare Biomarkers Product

Table 106. Bruker Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 107. Bruker Recent Development

Table 108. Siemens Healthineers Company Details

Table 109. Siemens Healthineers Business Overview

Table 110. Siemens Healthineers Rare Biomarkers Product

Table 111. Siemens Healthineers Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 112. Siemens Healthineers Recent Development

Table 113. Epigenomics Company Details

Table 114. Epigenomics Business Overview

Table 115. Epigenomics Rare Biomarkers Product

Table 116. Epigenomics Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 117. Epigenomics Recent Development

Table 118. GE HealthCare Company Details

Table 119. GE HealthCare Business Overview

Table 120. GE HealthCare Rare Biomarkers Product

Table 121. GE HealthCare Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 122. GE HealthCare Recent Development

Table 123. Diaceutics Company Details

Table 124. Diaceutics Business Overview

Table 125. Diaceutics Rare Biomarkers Product

Table 126. Diaceutics Revenue in Rare Biomarkers Business (2019-2024) & (US$ Million)

Table 127. Diaceutics Recent Development

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Rare Biomarkers Picture

Figure 2. Global Rare Biomarkers Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Rare Biomarkers Market Share by Type: 2023 VS 2030

Figure 4. Circulating Cell Free DNA (ccfDNA) Features

Figure 5. Circulating Tumor Cells (CTCs) Features

Figure 6. Exosomes/Extracellular Vesicles Features

Figure 7. Circulating Cell Free RNA (ccfRNA) / miRNA Features

Figure 8. Global Rare Biomarkers Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Rare Biomarkers Market Share by Application: 2023 VS 2030

Figure 10. Diagnostics Case Studies

Figure 11. Drug Development Case Studies

Figure 12. Disease Discovery Case Studies

Figure 13. Other Case Studies

Figure 14. Rare Biomarkers Report Years Considered

Figure 15. Global Rare Biomarkers Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Rare Biomarkers Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Rare Biomarkers Market Share by Region: 2023 VS 2030

Figure 18. Global Rare Biomarkers Market Share by Players in 2023

Figure 19. Global Top Rare Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Biomarkers as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Rare Biomarkers Revenue in 2023

Figure 21. North America Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Rare Biomarkers Market Share by Country (2019-2030)

Figure 23. United States Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Rare Biomarkers Market Share by Country (2019-2030)

Figure 27. Germany Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Rare Biomarkers Market Share by Region (2019-2030)

Figure 35. China Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Rare Biomarkers Market Share by Country (2019-2030)

Figure 43. Mexico Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Rare Biomarkers Market Share by Country (2019-2030)

Figure 47. Turkey Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. UAE Rare Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Roche Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 52. Abbott Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 53. Qiagen Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 54. PerkinElmer Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 55. Merck KGaA Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 57. Enzo Biochem Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 58. Charles River Laboratories International Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 59. Eurofins Scientific Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 60. Agilent Technologies Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 61. Bruker Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 62. Siemens Healthineers Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 63. Epigenomics Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 64. GE HealthCare Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 65. Diaceutics Revenue Growth Rate in Rare Biomarkers Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimer s Disease Biomarker Market Research Report 2024

Global Imaging Biomarker Market Research Report 2025

Global Tumor Biomarker Test Market Research Report 2024

Global Predisposition Biomarkers Market Research Report 2024

Global Rare Biomarkers Specimen Collection And Stabilization Market Insights Forecast to 2030

Global Circulating Biomarker for Liquid Biopsy Market Research Report 2024

Global Biomarker POCT Market Research Report 2024

Rare Disease Genetic Testing Market

Global Rare Disease Therapeutic Market Research Report 2024

Global Rare Amino Acid Market Research Report 2025

Stool Biomarkers Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac Biomarkers Testing Device Market Research Report 2025

Global Antibodies and Antigens to Cardiovascular Biomarkers Market Research Report 2025

Global Biomarkers for Signing Cancer Market Research Report 2025

Global Renal Biomarker Market Research Report 2025

Global Breast Biopsy Marker Market Research Report 2024

Global Antibiotic Stewardship Biomarkers Market Research Report 2024

Global Rare Sugars Market Research Report 2024

Global Infectious Disease Biomarker Testing Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions